Dermatology Associates' clinical research facility is a provider of Phase II through Phase IV dermatology clinical trials. We are dedicated to conducting the highest quality of clinical research. Although the facility itself is newly established, Dr. Bernard Goffe has been practicing clinical research for nearly 25 years. He has served on the medical advisory board for the National Psoriasis Foundation and is a member of both the American Medical Association (AMA) and the American Academy of Dermatology (AAD).

Our 9000sq ft. facility is equipped to accommodate the needs of Dermatology Associates group practice and the clinical research program. Our center can provide phototherapy, laser and cosmetic services, phlebotomy, and surgical procedures such as biopsies. The site has 13 exam rooms and 2 surgery rooms. There is a large research storage room which contains a dedicated refrigerator for study medication, -70 degree Celsius freezer, a wall locker, and large capacity shelving space to accommodate study materials. In addition to our research space, there is a dedicated area for monitoring visits. The site is equipped with both dial-up phone and high speed internet lines for email and internet access. A copier and facsimile are available for the monitors to use as well.

Dr. Goffe's predominant research focus lies in psoriasis, a chronic skin condition characterized as a noncontagious inflammatory skin disease characterized by recurring reddish patches covered with silvery scales. He is well known for his efforts in the diagnosis and treatment of psoriasis. Dr. Goffe along with rheumatologist Dr. Philip Mease are well known for their published work in the Lancet; Etanercept in the Treatment of Psoriatic Arthritis, 2000.

Dr. Goffe has also played an instrumental role in clinical trials involving Enbrel in the treatment of Psoriasis. In February 2004, Enbrel received FDA approval for the treatment of Psoriasis. Dr. Goffe also has experience in the use of other conventional and new biological treatments such as topical steroids, oral retinoids, Methotrexate, PUVA, Remicade, Raptiva and Amevive.

Dr. Goffe has served as a principal investigator for numerous clinical trials. His staff includes two sub investigators: board certified dermatologist Dr. Clive Liu, and Ardeth Dunne, PAC. Our research department consists of one certified research coordinator and one non-certified research coordinator, a research assistant and administrator.

We pull our subjects from a diverse population of 2 million people.

Dermatology Associates uses a central IRB.

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• 10 year long term observation of patient who are being treated with Tacrolimus
• 5 year long term observation of patient who are being treated with Raptiva
• An open label pilot study to evaluate the efficacy and safety of Raptiva ® (efalizumab) in combination with narrow band phototherapy for the treatment of moderate to severe plaque psoriasis
• An open label pilot study to evaluate the efficacy and safety of Raptiva ® (efalizumab) in combination with narrow band phototherapy for the treatment of moderate to severe plaque psoriasis
• Psoriasis study for patients with moderate to severe plaque psoriasis using 2 different topical medications
• Registry of subjects on Enbrel ® (etanercept) for Treatment of Psoriasis
• Treatment of mild to moderate Psoriasis with protopic cream

For more information, please contact:

Rebekah Lysaker
Research Administrator
Dermatology Associates, PLLC
1730 Minor Avenue, Suite 1000
Seattle, WA 98101 USA
Phone: 206-267-2100
Fax: 206-267-2101
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on July 7, 2008